Daiichi Sankyo begins phase 3 ENVISAGE-TAVI AF study of once-daily Lixiana to treat patients with AF undergoing TAVI

Press/Media

Period	9 May 2017

Media coverage

Title	Daiichi Sankyo begins phase 3 ENVISAGE-TAVI AF study of once-daily Lixiana to treat patients with AF undergoing TAVI
Media name/outlet	PharmaBiz
Country/Territory	India
Date	9/05/17
URL	www.pharmabiz.com/NewsDetails.aspx?aid=101860&sid=2
Persons	George Dangas,